Lupin

In News

How an invasion of purple flowers made Iceland an Instagram paradise – and caused a biodiversity crisis - The Guardian

The Guardian - Dec 04, 2025

'Lupin the IIIrd The Movie - The Immortal Bloodline' Breaks into Theaters in January with GKIDS - Animation Magazine

Animation Magazine - Dec 02, 2025

GKIDS Sets U.S. Release For Takeshi Koike’s New 'Lupin III' Film - Cartoon Brew

Cartoon Brew - Dec 02, 2025

Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™ - PR Newswire

PR Newswire - Nov 14, 2025

Guardian Feature Rekindles Debate Over Iceland’s Expanding Lupin Fields - Iceland Review

Iceland Review - Dec 05, 2025

GKIDS Announces ‘Lupin the IIIRD: The Immortal Bloodline’ US Theatrical Release Dates - hypebeast.com

hypebeast.com - Dec 03, 2025

Lupin Announces New U.S. Manufacturing Facility and $250 Million Domestic Investment - Association for Accessible Medicines

Association for Accessible Medicines - Oct 09, 2025

Lupin Eyes Global Ophthalmology Growth - Citeline News & Insights

Citeline News & Insights - Dec 01, 2025

Lupin the IIIrd: The Movie - The Immortal Bloodline - Official Trailer - IGN

IGN - Dec 02, 2025

Sandoz will license Lupin's ranibizumab biosimilar in Europe, other select regions - Ophthalmology Times Europe

Ophthalmology Times Europe - Aug 12, 2025

Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla. - Fierce Pharma

Fierce Pharma - Oct 09, 2025

Lupin gets USFDA nod for multiple sclerosis drug - The Economic Times

The Economic Times - Dec 05, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment